Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Lacosamide Patent Expiration

Lacosamide is Used for treating partial-onset seizures in patients with epilepsy aged 17 years and older, either as adjunctive therapy or when oral treatment is temporarily not feasible. It was first introduced by Ucb Inc in its drug Vimpat on Oct 28, 2008. Another drug containing Lacosamide is Motpoly Xr. 33 different companies have introduced drugs containing Lacosamide.


Lacosamide Patents

Given below is the list of patents protecting Lacosamide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Motpoly Xr US11337943 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Motpoly Xr US11883374 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Motpoly Xr US12042474 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Vimpat USRE38551 Anticonvulsant enantiomeric amino acid derivatives Mar 17, 2022

(Expired)

 Ucb Inc
Vimpat US5654301 Amino acid derivative anticonvulsant Aug 05, 2014

(Expired)

 Ucb Inc



Lacosamide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lacosamide Generic API Manufacturers

Several generic applications have been filed for Lacosamide. The first generic version for Lacosamide was by Mylan Pharmaceuticals Inc and was approved on Apr 28, 2016. And the latest generic version is by Acella Pharmaceuticals Llc and was approved on Nov 14, 2024.

Given below is the list of companies who have filed for Lacosamide generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Discontinued ORAL N/A Jul 12, 2022
150MG

tablet Discontinued ORAL N/A Jul 12, 2022
100MG

tablet Discontinued ORAL N/A Jul 12, 2022
50MG

tablet Discontinued ORAL N/A Jul 12, 2022





2. ACELLA

Acella Pharmaceuticals Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Acella.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Nov 14, 2024


Manufacturing Plant Locations
New

Acella's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Acella as present at those locations.

Country City Firm Name
United States
Alpharetta Acella Pharmaceuticals, LLC





3. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Discontinued ORAL N/A Jan 5, 2023
50MG

tablet Discontinued ORAL N/A Jan 5, 2023
150MG

tablet Discontinued ORAL N/A Jan 5, 2023
200MG

tablet Discontinued ORAL N/A Jan 5, 2023





4. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)





5. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 31, 2022
200MG

tablet Prescription ORAL AB Mar 31, 2022
150MG

tablet Prescription ORAL AB Mar 31, 2022
100MG

tablet Prescription ORAL AB Mar 31, 2022
10MG/ML

solution Prescription ORAL AA May 19, 2022





6. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Discontinued ORAL N/A Mar 17, 2022
150MG

tablet Discontinued ORAL N/A Mar 17, 2022
200MG

tablet Discontinued ORAL N/A Mar 17, 2022
50MG

tablet Discontinued ORAL N/A Mar 17, 2022
10MG/ML

solution Discontinued ORAL N/A Mar 27, 2024





7. APOTEX

Apotex Inc has filed for 6 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Sep 23, 2022
100MG

tablet Discontinued ORAL N/A Sep 23, 2022
50MG

tablet Discontinued ORAL N/A Sep 23, 2022
200MG

tablet Discontinued ORAL N/A Sep 23, 2022
10MG/ML

solution Prescription ORAL AA Sep 26, 2022
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Nov 13, 2023


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





8. ASPIRO

Aspiro Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Sep 14, 2022


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





9. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Jan 5, 2023
100MG

tablet Prescription ORAL AB Jan 5, 2023
150MG

tablet Prescription ORAL AB Jan 5, 2023
200MG

tablet Prescription ORAL AB Jan 5, 2023
10MG/ML

solution Prescription ORAL AA Jan 24, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





10. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA May 15, 2024





11. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Mar 25, 2024





12. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP May 3, 2022


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





13. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Sep 19, 2022





14. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022





15. HAINAN POLY

Hainan Poly Pharm Co Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hainan Poly.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Feb 13, 2024


Manufacturing Plant Locations
New

Hainan Poly's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly as present at those locations.

Country City Firm Name
China
Haikou Hainan Poly Pharm. Co., Ltd.





16. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA May 31, 2022





17. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022





18. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Apr 5, 2024


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





19. INDOCO

Indoco Remedies Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Indoco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
50MG

tablet Prescription ORAL AB Mar 17, 2022
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Apr 7, 2022


Manufacturing Plant Locations
New

Indoco's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Indoco as present at those locations.

Country City Firm Name
India
Taluka Khalapur, District Raigad Indoco Remedies Limited
Verna Indoco Remedies Limited
Verna Indoco Remedies Limited (Plant I)
Navi Mumbai Indoco Remedies Limited





20. KANCHAN HLTHCARE

Kanchan Healthcare Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Kanchan Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Apr 2, 2024
50MG

tablet Prescription ORAL AB Apr 2, 2024
100MG

tablet Prescription ORAL AB Apr 2, 2024
150MG

tablet Prescription ORAL AB Apr 2, 2024





21. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB May 24, 2024
150MG

tablet Prescription ORAL AB May 24, 2024
100MG

tablet Prescription ORAL AB May 24, 2024
50MG

tablet Prescription ORAL AB May 24, 2024





22. MEDLEY PHARMS

Medley Pharmaceuticals Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Medley Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA Feb 6, 2023





23. MSN

Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Feb 9, 2023
10MG/ML

solution Prescription ORAL AA Dec 22, 2023


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Kamareddy MSN Life Sciences Private Limited
Sangareddy MSN Pharmachem Private Limited
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Laboratories Private Limited, R&D Center
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Yadadri Bhuvanagiri District MSN Organics Private Limited
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Sangareddy MSN Laboratories Private Ltd.
Isnapur MSN Laboratories Private Limited, Unit-II
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
United States
Piscataway MSN PHARMACEUTICALS INC





24. MSN LABS PVT LTD

Msn Laboratories Private Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn Labs Pvt Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022





25. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Prescription ORAL AB Apr 28, 2016
50MG

tablet Prescription ORAL AB Apr 28, 2016
200MG

tablet Prescription ORAL AB Apr 28, 2016
100MG

tablet Prescription ORAL AB Apr 28, 2016





26. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA Aug 26, 2022


Manufacturing Plant Locations
New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country City Firm Name
United States
East Windsor Novitium Pharma LLC





27. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Mar 17, 2022
50MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022





28. SOMERSET THERAPS LLC

Somerset Therapeutics Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Oct 9, 2024





29. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
50MG

tablet Prescription ORAL AB Mar 17, 2022


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
India
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra Sun Pharmaceutical Industries Limited
Baruch Sun Pharmaceutical Industries Ltd.





30. UNICHEM

Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Sep 4, 2024
150MG

tablet Prescription ORAL AB Sep 4, 2024
100MG

tablet Prescription ORAL AB Sep 4, 2024
50MG

tablet Prescription ORAL AB Sep 4, 2024


Manufacturing Plant Locations
New

Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.

Country City Firm Name
India
Ghaziabad Unichem Laboratories Ltd.
Mumbai Unichem Laboratories Limited
Kolhapur Unichem Laboratories Limited
Pilerne Bardez Unichem Laboratories Limited
Pithampur Unichem Laboratories Limited
District Raigad Unichem Laboratories Ltd
United States
Hasbrouck Heights Unichem Pharmaceuticals Usa Inc
East Brunswick Unichem Pharmaceuticals USA Inc.





31. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Jun 29, 2022
100MG

tablet Discontinued ORAL N/A Dec 15, 2023
50MG

tablet Discontinued ORAL N/A Dec 15, 2023
200MG

tablet Discontinued ORAL N/A Dec 15, 2023
150MG

tablet Discontinued ORAL N/A Dec 15, 2023